Market closedNon-fractional

Prestige Consumer Healthcare/PBH

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Prestige Consumer Healthcare

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Ticker

PBH

Sector

Healthcare

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Tarrytown, United States

Employees

570

PBH Metrics

BasicAdvanced
$3.4B
Market cap
16.37
P/E ratio
$4.17
EPS
0.53
Beta
-
Dividend rate
$3.4B
0.53
3.204
1.907
68.486
68.858
5.10%
6.42%
13.50%
16.37
3.02
2.05
-2.85
14.19
-0.21%
-352.73%
6.06%
8.66%

What the Analysts think about PBH

Analyst Ratings

Majority rating from 6 analysts.
Buy

PBH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
17.84% profit margin
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$277M
-2.05%
Net income
$49M
-6.79%
Profit margin
17.84%
-4.80%

PBH Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 14.09%
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$1.06
$1.07
$1.06
$0.98
-
Expected
$1.01
$1.07
$1.04
$1.14
$0.86
Surprise
4.99%
0.34%
1.81%
-14.09%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Prestige Consumer Healthcare stock?

Prestige Consumer Healthcare (PBH) has a market cap of $3.4B as of July 04, 2024.

What is the P/E ratio for Prestige Consumer Healthcare stock?

The price to earnings (P/E) ratio for Prestige Consumer Healthcare (PBH) stock is 16.37 as of July 04, 2024.

Does Prestige Consumer Healthcare stock pay dividends?

No, Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Prestige Consumer Healthcare dividend payment date?

Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders.

What is the beta indicator for Prestige Consumer Healthcare?

Prestige Consumer Healthcare (PBH) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Prestige Consumer Healthcare stock

Buy or sell Prestige Consumer Healthcare stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing